2020
DOI: 10.1016/j.annonc.2020.08.027
|View full text |Cite
|
Sign up to set email alerts
|

909P Efficacy and safety of HHPG-19K for prophylaxis of chemotherapy-induced neutropenia in patients with lymphoma

Abstract: Conclusions: This study provided new evidence for HHPG-19K, which would be a new alternative clinical practice for prophylaxis of chemotherapy induced neutropenia.Legal entity responsible for the study: The authors.

Help me understand this report

This publication either has no citations yet, or we are still processing them

Set email alert for when this publication receives citations?

See others like this or search for similar articles